Founded in 2006, Amplexa Genetics is one of the world's longest-existing private genetic laboratories. The company is among the pioneers in the sale of genetic analyzes. We have always focused on high quality and usability in our work, and we know how important it is for our survey results!



Our mission is to provide knowledge that can help individuals make decisions. Whether you are private or professional, the results of our research help you plan what your family should look like or what treatment to choose for your patient.


Our vision is to develop our position as an internationally recognized partner and supplier of functional genetic analyses and become the field's favorite. 


Amplexa Genetics, together with recognized and respected scientific experts, has developed more than 100 different clinical genetic tests. They are mainly distributed in neurology, endocrinology, cardiology, and oncology.

 The tests we perform cover highly significant genes where the published scientific literature supports the disease-causing consequence of variants in the genes.

Amplexa Genetics has a strong network of specialists with competencies in genetics and genetic research - they are available with help in interpreting unique variants or variants that are difficult to interpret.


Amplexa Genetics applies state-of-the-art instrumentation and cutting edge technologies combined with inhouse developed bioinformatic pipelines.

For our routine disease exome and panel screening. For our clinical exome and panel analyses we use novel Next Generation Sequencing (NGS) platforms and Sanger sequencing (Standard Capillary Electrophoresis) for verification.

We deliver Single cell RNA sequencing and expression profiling as well as ATAC sequencing for chromatin accessibility and epigenetic regulation.  This is performed on the latest technolgies available like 10X Genomics and Parse Evercode etc. This is combined with a strong bioinformatic team for data processing and visualization.


Amplexa Genetics annually supports two different voluntary organizations. For many years, as for this year, it has been the Danish Refugee Council. Migration has been the background for us developing into the people we are today. At present, in many places, this migration is involuntary and in the wake of wars, conflicts, and disasters. We want to help these people to have a better life.

The second organization Amplexa Genetics supports is the Danish Hospital Clowns, which has benefited hospitalized children throughout their illness. They spread smiles and joy with hospitalized children and families when needed the most.


Rikke Steensbjerre Møller, Cand.scient, Ph.d

Head of genetic research, Danish Epilepsy Center Filadelfia, Dianalund


Deb Pal, MD, Ph.D., MRCP

Professor of Pediatric Epilepsy, King's College London


Henriette Roed Nielsen
Clinical geneticist. Medical Director European Sperm Bank

Amplexa Genetics collaborates with more than 100 reputable hospitals, laboratories, and doctors worldwide and provides the best professional service.
It supports their work with clinical diagnoses.